Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mixed incontinence.

Charlotte Chaliha1, Vik Khullar

  • 1Department of Urogynaecology, St. Mary's Hospital, Imperial College, London, United Kingdom.

Urology
|March 12, 2004
PubMed
Summary
This summary is machine-generated.

Mixed incontinence, a combination of stress and urge symptoms, affects many women. Antimuscarinic agents like tolterodine show promise as an initial treatment, though more research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Uropathogen Distribution in Relation to the COVID-19 Pandemic Timeline.

International urogynecology journal·2026
Same author

Systematic Review and Meta-Analysis of Bladder Wall Thickness for the Diagnosis of Detrusor Overactivity in Women.

International urogynecology journal·2026
Same author

How Can We Improve the Assessment and Indifferent Outcomes From Pelvic Organ Prolapse Management From Conservative and Surgical Therapies? ICI-RS 2025.

Neurourology and urodynamics·2026
Same author

Joint hypermobility syndrome for the urogynaecologist - A narrative review.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

What Evidence Do We Need From Objective and Subjective Outcomes in Order to Recommend Specific Operative Procedures for Men to Relieve BPO and Women With SUI? ICI-RS 2025.

Neurourology and urodynamics·2025
Same author

Is There Adequate Evidence for Intracellular Bacteria Being a Significant Cause of rUTIs and Thereby Justifying Targeted Treatments Such as Bladder Fulguration or Intravesical Therapies? ICI-RS 2025.

Neurourology and urodynamics·2025
Same journal

Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in U.S. Coverage of Pelvic Floor Muscle Therapy.

Urology·2026
Same journal

Editorial Comment on "Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match".

Urology·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
Same journal

Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

Urology·2026
Same journal

Intractable Epistaxis and Severe Hypertension in a Young Woman.

Urology·2026
See all related articles

Area of Science:

  • Urology
  • Gynecology
  • Pharmacology

Background:

  • Mixed incontinence, combining stress and urge symptoms, is prevalent in women (approx. 33%) but understudied.
  • This condition often presents treatment challenges, with limited efficacy for current pharmacologic and surgical options.

Purpose of the Study:

  • To review the current understanding of mixed incontinence epidemiology and treatment.
  • To evaluate the efficacy of various pharmacologic agents and surgical interventions for mixed incontinence.

Main Methods:

  • Literature review of studies on mixed incontinence treatment.
  • Analysis of clinical trial data for antimuscarinic agents (tolterodine) and serotonin/norepinephrine reuptake inhibitors (duloxetine oxalate).
  • Examination of limited surgical outcome data for mixed incontinence.

Related Experiment Videos

Main Results:

  • Tolterodine, an antimuscarinic, significantly reduced incontinence episodes and improved urgency in a large trial.
  • Estrogen therapy yielded conflicting results for mixed incontinence.
  • Duloxetine oxalate demonstrated potential for stress and possibly mixed incontinence, showing favorable effects on bladder capacity.

Conclusions:

  • Antimuscarinic agents are supported as a first-line therapy for mixed incontinence.
  • Further long-term studies are necessary to determine the sustained benefits of treatments for mixed incontinence.